The proposed improvements to Hong Kong’s valuation industry set out by the International Valuation Standards Council and Business Valuation Quality Initiative Task Force
Edmund Wong, Legislative Council member, Rebecca Chan, CFO of Cloudbreak Pharma, and Nami Wong, member of the Institute's Young Members Committee, share their insights on what to look out for in 2025
We use cookies to give you the best experience of our website. By continuing to browse the site, you agree to the use of cookies for analytics and personalized content. To learn more, visit our privacy policy page. View more
